Professor Sir Roy Anderson FRS FMedSci
London Centre for Neglected Tropical Disease Research
Sir Roy is Professor of Infectious Disease Epidemiology in the School of Public Health, Imperial College London and Director of the London Centre for Neglected Tropical Disease Research.
Sir Roy served as Director of the Wellcome Centre for Parasite Infections (1989 – 1993 at Imperial College London) and Director of the Wellcome Centre for the Epidemiology of Infectious Disease (1993 – 2000 at the University of Oxford). He is the author of over 450 scientific articles and has sat on numerous government and international agency committees advising on public health and disease control including the World Health Organisation and UNAIDS.
He has also served as Chair of the Science Advisory Board of the Natural History Museum London, and as a non-executive director of GlaxoSmithKline.
He is currently Chair of Oriole Global Health Ltd, Chair of the International Advisory Board of PTTGC Thailand, and a member of the International Advisory Board of Hakluyt and Company Ltd. He is also a member of the Advisory Board of Oxford Nanoimaging and serves on the Board of the London Institute of Mathematical Sciences.
Sir Roy was elected Fellow of the Royal Society in 1986, a Founding Fellow of the Academy of Medical Sciences in 1998, and a Foreign Associate Member of the National Academy of Medicine at the US National Academy of Sciences in 1999. He was knighted in the 2006 Queen’s Birthday Honours.
Professor Jonathan Carapetis AM FAHMS
Telethon Kids Institute
Professor Carapetis is the Director of the Telethon Kids Institute in Perth, Western Australia. He is also a Professor at the University of Western Australia and consultant paediatrician at Perth Children’s Hospital.
His research interests include Rheumatic fever and rheumatic heart disease, other group A streptococcal diseases, Vaccine-preventable disease, Indigenous child health, Child development and education, Youth health and education and skin sores and scabies.
Professor Carapetis undertook his medical training at the Royal Melbourne and Royal Children’s Hospitals. Previous positions include terms as Theme Director at the Murdoch Children’s Research Institute in Melbourne and Director of the Menzies School of Health Research in Darwin.
The Burnet Institute
Professor Margaret Hellard AM is a Deputy Director at the Burnet Institute, Head of Hepatitis Services in the Infectious Diseases Unit at The Alfred Hospital and an Adjunct Professor of Infectious Diseases Epidemiology at Monash University and University of Melbourne in Melbourne, Australia.
Margaret’s principal research interests are in preventing the transmission and improving the management of blood borne viruses and sexually transmitted infections, with the ultimate aim to end the AIDS epidemic and eliminate viral hepatitis as a public health threat.
She has considerable experience in undertaking multidisciplinary community based research involving people who inject drugs (PWID), gay and bisexual men (GBM) and other vulnerable populations.
Margaret is a member of numerous advisory committees and working groups on viral hepatitis and HIV within Australia and globally, including Co-Chairing the WHO Strategic and Technical Advisory Group on HIV and Viral Hepatitis and Chairing the World Innovation Health Summit Viral Hepatitis Forum (2018).. She has over 400 peer reviewed publications and received over $80 million in competitive grants and tenders.
The Peter Doherty Institute for Infection and Immunity
Professor Sharon Lewin is the inaugural director of the Peter Doherty Institute for Infection and Immunity, a joint venture between the University of Melbourne and Royal Melbourne Hospital; Professor of Infectious Diseases, The University of Melbourne; consultant infectious diseases physician, Alfred Hospital and a National Health and Medical Research Council (NHMRC) Practitioner Fellow, Melbourne, Australia.
She is an infectious diseases physician and basic scientist. Her research focuses on understanding why HIV persists on treatment and developing clinical trials aimed at ultimately finding a cure for HIV infection. She has also had a long standing interest in the natural history and management of HIV-hepatitis B co-infection. She has given over 100 major invited talk internationally on the topic of an HIV cure and leads several large multi-centre collaborative grants on HIV cure.
She is an elected member of the Governing Council of the International AIDS Society (IAS) representing the Asia Pacific region and co-chairs the IAS Global Advisory board for the Towards an HIV Cure initiative. She has been a member of the council of the National Health and Medical Research Council of Australia since 2016. In 2014 she was named Melburnian of the Year and in 2015 awarded the Peter Wills Medal from Research Australia. She was made an Officer of the Order of Australia in 2019.
The University of Western Australia
Barry Marshall with Robin Warren showed that Helicobacter pylori is the main cause of stomach and duodenal ulcers. Their discovery, recognized by the Nobel Prize for Medicine or Physiology, led to more effective ulcer treatments and to uncovering the link between H. pylori and stomach cancer. He continues to undertake clinical treatment and research into H. pylori diagnosis and eradication treatments. His strong industry connections have facilitated research translation. He invented and commercialised two gold standard diagnostic tests for H. pylori: the 14C Urea Breath Test (PYtest®), and the Rapid Urease Test (CLOtest®).
His research has expanded with his group to embrace new technologies including next generation sequencing, and genomic analysis. With local and international collaborators, the team are investigating many facets of H. pylori biology including possible beneficial effects on the immune system. His innovative thinking has recently led him to develop a novel approach for diagnosis of gastrointestinal disorders through artificial intelligence and analysis of bowel sounds.
In Barry Marshall was awarded the China Friendship Award, China’s highest honour to foreign experts. In 2016 he was Included in the Chinese Government’s “1000 Talents Plan”.
QIMR Berghofer Medical Research Institute
Professor James McCarthy is a Senior Scientist at QIMR Berghofer Medical Research Institute, and an Infectious Diseases Physician at Royal Brisbane and Womens Hospital, both in Brisbane, Australia. His clinical and research training were undertaken in Australia, the United Kingdom, at the University of Maryland and the Laboratory for Parasitic Diseases, National Institutes of Health, Bethesda, MD, before returning to Australia in 1997. A major focus of his research is the development and application of clinical trial systems that entail deliberate infection of human volunteers with malaria parasites by intravenous injection of Plasmodium-infected red blood cells. Volunteers are then studied in the pre-symptomatic period by qPCR to evaluate investigational drugs, vaccines and diagnostics for malaria.
The Peter Doherty Institute for Infection and Immunity
Jodie McVernon is Professor and Director of Epidemiology at the Peter Doherty Institute for Infection and Immunity. She is a physician with subspecialty qualifications in public health and vaccinology, and has extensive expertise in clinical vaccine trials, epidemiologic studies and mathematical modelling of infectious diseases, gained at the University of Oxford, Health Protection Agency London and The University of Melbourne. Her work seeks to advance understanding of the drivers of infectious disease epidemiology, to inform optimal interventions for disease preparedness, prevention and control.
The Peter MacCallum Cancer Centre and National Centre for Antimicrobial Stewardship
Professor Karin Thursky is an infectious diseases physician and clinician-researcher who is both nationally and internationally recognised as a leader and pioneer of antimicrobial stewardship in Australia. Prof. Thursky is the Deputy Head of infectious diseases at the Peter MacCallum Cancer Centre, Director (CIA) of the National Centre for Antimicrobial Stewardship, a health services Centre of Research Excellence (CRE) that works across both human and animal health.
She is also the Director of the Guidance Group at the Royal Melbourne Hospital, which develops and implements information technology tools for antimicrobial stewardship in hospitals; the implementation stream lead of the CRE National Centre for Infections in Cancer; the leader of the National Antimicrobial Prescribing Survey, which is the key contributor to Australia’s national antimicrobial use and resistance surveillance program; and the clinical lead of the Better Care Victoria-supported state-wide ‘Think sepsis. Act fast.’ program, which involves the state-wide implementation of an award-winning whole-of-hospital sepsis clinical pathway developed by her and her teams at the Peter MacCallum Cancer Centre and Royal Melbourne Hospital.
Professor Thursky is a clinician-researcher at the Departments of Medicine and Oncology, and the Peter Doherty Institute for Infection and Immunity at the University of Melbourne. She has both clinical and research experience across a very wide range of areas, including adult and paediatric infectious diseases; clinical epidemiology; prevention and treatment of infections in the immunocompromised host; antimicrobial stewardship in human and animal health; computerised decision support; immunology and biomarkers; natural language processing; antifungal stewardship; antibiotic allergy; sepsis; and health economics.
The Alfred Hospital and Monash University
Anton is a Professor of Infectious Diseases and Microbiology, and is the Director of the Department of Infectious Diseases at The Alfred Hospital and Central Clinical School, Monash University.
He completed his infectious diseases clinical training in Australia in 2005 and then went to the USA for four years and worked at the Harvard-affiliated hospitals; Beth Israel Deaconess Medical Center and Massachusetts General Hospital. He completed a Masters of Public Health at Harvard School of Public Health, and also completed a PhD in Infectious Diseases and Microbiology.
His research interests are in hospital-acquired infections, antibiotic resistance, mechanisms of pathogenesis and infections in immunocompromised hosts. He is also an active clinician working in the area of hospital-acquired infections and transplant infectious diseases. He is a committee member of the Clinical Research Network of the Australasian Society of Infectious Diseases and the Taskforce against Multidrug-resistant Gram-negative Bacteria for the Australian Commission on Safety and Quality in Healthcare. He has received numerous national and international awards for his advanced research and contribution to Infectious Diseases and Microbiology.
Coalition for Epidemic Preparedness Innovations (CEPI)
Melanie Saville joined the Coalition for Epidemic Preparedness Innovations (CEPI) in November 2017. In her role as Director vaccine development, Melanie leads a technical team who have oversight of the CEPI funded vaccines in development. Melanie is a physician specialized in virology with 20 yrs of experience in the development and licensure of vaccines for the developed and developing world. Over the years, she has contributed to the development and licensure of several vaccines for seasonal and pandemic influenza, pediatric combinations, Rabies, Japanese Encephalitis and Dengue vaccine in Europe, US and the international area.
Melanie obtained her medical degree from University College, London in 1993. She also obtained a Bachelor of Science in Molecular Biology from University College, London and a master’s in medical Virology from Imperial College, London.
In the vaccine industry, Melanie has held positions of increasing responsibility in research and development working for Wyeth, Sanofi Pasteur and Janssen vaccines and prevention.
The Marie Bashir Institute for Infectious Diseases and Biosecurity
Professor Tania Sorrell is Professor of Clinical Infectious Diseases, Director of the Marie Bashir Institute for infectious Diseases and Biosecurity and Deputy Dean, Sydney Medical School, the University of Sydney, Australia; Director of the Centre for Infectious Diseases and Microbiology, Westmead Institute for Medical Research, Westmead, NSW; and Service Director, Infectious Diseases and Sexual Health, Western Sydney Local Health District. She has had a longstanding clinical interest in mycology and infections in the immunocompromised host and a more recent interest in emerging infectious diseases. Her research has focussed on the pathogenesis of fungal infections, emerging fungal diseases, new antifungal drug development, new diagnostics and clinical trials of antifungal diagnostic and treatment strategies. She has served on state and national advisory committees in Infectious Diseases and therapeutics and the Research and Human Ethics Committees of NHMRC.
WHO Collaborating Centre for Reference and Research on Influenza
Dr Kanta Subbarao is the Director of the WHO Collaborating Centre for Reference and Research on Influenza at the Peter Doherty Institute for Infection and Immunity and Professor, Department of Microbiology and Immunology, The University of Melbourne. She is a virologist and a physician with specialty training in pediatrics and pediatric infectious diseases. Previously, she was Chief of the Emerging Respiratory Viruses Section of the Laboratory of Infectious Diseases, of the National Institute of Allergy and Infectious Diseases (NIAID), NIH in the USA. Dr. Subbarao’ s research has focused on newly emerging viral diseases of global importance including pandemic influenza, severe acute respiratory syndrome (SARS) and Middle East Respiratory Syndrome (MERS) coronaviruses. In her current position, she advises the World Health Organization on viruses to be included in annual seasonal influenza vaccines.
Her current research efforts are directed at understanding the biology and immune responses to influenza viruses and vaccines. She is a Fellow of the American Academy of Microbiology and the Infectious Diseases Society of America. She serves on the Editorial Board of PLoS Pathogens and mBio.